Download video

Exploring the Tazemetostat Approval in R/R Follicular Lymphoma

619 views

Targeted Oncology

4 years ago

Exploring the Tazemetostat Approval in R/R Follicular Lymphoma

Exploring the Tazemetostat Approval in R/R Follicular Lymphoma

Exploring the Tazemetostat Approval in R\/R Follicular Lymphoma
1:31
Exploring the Tazemetostat Approval in R\/R Follicular Lymphoma
by Targeted Oncology
Accelerated Approval of Tazemetostat For Follicular Lymphoma
3:55
Accelerated Approval of Tazemetostat For Follicular Lymphoma
by CheckRare
Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma
1:16
Dr. Leonard on the FDA Approval of Tazemetostat in Follicular Lymphoma
by OncLive
Trial-in-progress: tazemetostat with rituximab for R\/R follicular lymphoma
1:31
Trial-in-progress: tazemetostat with rituximab for R\/R follicular lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. Maddocks on the Role of Tazemetostat in EZH2-Mutant Follicular Lymphoma
1:11
Dr. Maddocks on the Role of Tazemetostat in EZH2-Mutant Follicular Lymphoma
by OncLive
Tazemetostat and rituximab in r\/r follicular lymphoma
0:38
Tazemetostat and rituximab in r\/r follicular lymphoma
by VJHemOnc – Video Journal of Hematology \& HemOnc
Dr. Burke on Tazemetostat’s Mechanism of Action in EZH2-Mutated Follicular Lymphoma
1:35
Dr. Burke on Tazemetostat’s Mechanism of Action in EZH2-Mutated Follicular Lymphoma
by OncLive
Dr. Leslie on Phase 1b Trial of Tazemetostat Plus Lenalidomide\/Rituximab in Follicular Lymphoma
1:15
Dr. Leslie on Phase 1b Trial of Tazemetostat Plus Lenalidomide\/Rituximab in Follicular Lymphoma
by OncLive
ETCTN P10500: a Phase I\/expansion study of tazemetostat plus belinostat for R\/R NHL
3:44
ETCTN P10500: a Phase I\/expansion study of tazemetostat plus belinostat for R\/R NHL
by VJHemOnc – Video Journal of Hematology \& HemOnc
Tazemetostat for the treatment of R\/R FL
10:16
Tazemetostat for the treatment of R\/R FL
by Lymphoma Hub
Novel Agents for R\/R Follicular Lymphoma Management
7:23
Novel Agents for R\/R Follicular Lymphoma Management
by curetoday
FDA Approval in CLL and FL, Partial Hold Lifted in Tazmetostat Trials, and More
11:13
FDA Approval in CLL and FL, Partial Hold Lifted in Tazmetostat Trials, and More
by OncLive
Ribrag: Phase 1 Results for Tazemetostat
1:57
Ribrag: Phase 1 Results for Tazemetostat
by Cancer Therapy Advisor
John Gerecitano, MD, on predictors of response to tazemetostat in diffuse large B-cell lymphoma
1:16
John Gerecitano, MD, on predictors of response to tazemetostat in diffuse large B-cell lymphoma
by OBRoncology
Current and Future Role of EZH1\/2 Inhibitors in the Care of Patients with Lymphoma
56:01
Current and Future Role of EZH1\/2 Inhibitors in the Care of Patients with Lymphoma
by Research To Practice
Follicular Lymphoma - Anti-tumor action of tazometostat
3:46
Follicular Lymphoma - Anti-tumor action of tazometostat
by Kevin Fanning
Tazemetostat for treatment of epitheloid sarcoma (New Drug 2020)
3:32
Tazemetostat for treatment of epitheloid sarcoma (New Drug 2020)
by Ranjan Kumar Patel
Emerging Therapies in Follicular Lymphoma
7:21
Emerging Therapies in Follicular Lymphoma
by Targeted Oncology
Dr. Michael Dickinson: Tazemetostat in FL and DLBCL – ICML 2017
4:55
Dr. Michael Dickinson: Tazemetostat in FL and DLBCL – ICML 2017
by Lymphoma Hub
Frontline Treatment for Newly Diagnosed Follicular Lymphoma
4:10
Frontline Treatment for Newly Diagnosed Follicular Lymphoma
by Targeted Oncology